AUCTUS Capital Partners AG has successfully sold a majority stake in PharmaLex, a leading pharma services group, to AmerisourceBergen Corporation, marking a significant advancement in enhancing global pharmaceutical solutions.

Information on the Target

PharmaLex is a prominent pharmaceutical services group that specializes in providing a comprehensive range of services tailored to the life sciences sector. With a global team of experts in scientific, regulatory, and safety compliance (GxP), PharmaLex guides biopharma companies through every stage of a product's lifecycle. Their offerings include tech-enabled services spanning clinical development consulting to marketing authorization, aimed at facilitating the efficient entry of client products into international markets and diverse patient demographics.

Headquartered in Germany, PharmaLex has successfully expanded its global presence, establishing a significant operational footprint in both Europe and the United States, while also increasing its influence in emerging markets worldwide.

Industry Overview in Germany

The pharmaceutical services industry in Germany is characterized by a robust regulatory environment and a rich ecosystem of companies involved in research and development activities. Germany stands as one of the leading count